Plexium
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
11494 Sorrento Valley Rd Ste A, San Dieg...Phone Number
(858) 263-7491Website
www.plexium.comRevenue
$10.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Plexium
Plexium is a biotechnology company focused on the identification of E3 ligase modulating small molecules to treat cancer and neurodegenerative diseases. The company's screening platform, named DELPhe for DNA-Encoded Library phenotypic screening, utilizes droplet and microwell confinement to miniaturize cell-based assays that yield high content readouts at very low cost and very high throughput.Explore more
Plexium Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Plexium your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Plexium has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Plexium, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Plexium had a recent Job posting/layoffs
Check if Plexium has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Plexium launches new products
Check out if Plexium is spiking on competitors!
Earning: See what the market has to say on Plexium recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Plexium
Recommended Actions
Find VP level buyers at Plexium
Find 2 more new buyers
Compare Similar Companies to Plexium
Compare insights from companies similar to Plexium, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Plexium is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Plexium is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Plexium.
Plexium financials insights
Gather financial insights about Plexium, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$28M
2021
Other Financing Round
$35M
2022
Other Financing Round
$102M
2025
Private Equity
$60.1M
Plexium Tech Stack
A closer look at the technologies used by Plexium
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Layoffs
Project
Layoffs, Corporate Strategy
Person-Based
Person-Based
Plexium News & Media
Plexium Announces Multiple Presentations at AACR 2025 with Selective Monovalent Degrader Programs Targeting SMARCA2, IKZF2 and CDK2
-PLX-61639, a selective, oral SMARCA2 degrader, demonstrated sustained PD response and single-agent efficacy in SMARCA4 mutant tumors; program is advancing through IND-enabling studies- -PLX-4545, a selective IKZF2 molecular glue degrader, completely degraded IKZF2 across a range of...Plexium Announces Two Oral Presentations and Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
SAN DIEGO, April 2, 2025 /PRNewswire/ -- Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation company, today announced that initial Phase 1 clinical results with PLX-4545, a selective IKZF2 molecular glue degrader, and preclinical results from the Company's...Plexium Announces Appointment of Jorge F. DiMartino, M.D., Ph.D. as Chief Medical Officer
SAN DIEGO, Oct. 1, 2024 /PRNewswire/ -- Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation company, today announced that it has appointed Jorge F. DiMartino, M.D., Ph.D., as Chief Medical Officer and Executive Vice President of Clinical and Translational...Plexium Announces Appointment of Michael Martin, Ph.D. as President and CEO
SAN DIEGO, Jan. 16, 2024 /PRNewswire/ -- Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Michael Martin, Ph.D. as President and Chief Executive Officer, and a member of the Board of Directors. Dr. Martin...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Plexium
Sign Up For FreeTo access detailed company insights
Plexium is a biotechnology company focused on the identification of E3 ligase modulating small molecules to treat cancer and neurodegenerative diseases. The company's screening platform, named DELPhe for DNA-Encoded Library phenotypic screening, utilizes droplet and microwell confinement to miniaturize cell-based assays that yield high content read... Read More
